Company / Working Capital
Collegium Pharmaceutical, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$251.4M
FY2025
5-year range
-$27.3M / $251.4M
FY2021-FY2025
Trend
+1022.4%
vs FY2024
Sector context
#157 of 213
Health Care
What the data says
Working Capital changed +1022% YoY in FY2025, a notable deviation from the 9-year average annual change of +148%.
Based on SEC 10-K filings.
$251M in FY2025 with a 5-year CAGR of +45.6%.
Improved from $80M to $251M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +45.6%
- 10-Year CAGR
- -
Sector benchmark
#157 of 213 in Health CareTop 74% of 213This company $251.4M Sector average $934.6M
▼
-73.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +45.6%, indicating consistent growth.
- In FY2025, working capital increased 1022.4% year-over-year.
- Ranks #157 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $251.4M | +1022.4% |
| FY2024 | -$27.3M | -134.2% |
| FY2023 | $79.7M | +680.1% |
| FY2022 | -$13.7M | -138.2% |
| FY2021 | $36.0M | -6.4% |
| FY2020 | $38.4M | -28.8% |
| FY2019 | $54.0M | +11.5% |
| FY2018 | $48.4M | -52.6% |
| FY2017 | $102.0M | -23.3% |
| FY2016 | $133.0M | +50.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026